Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series

Idiopathic nephrotic syndrome (INS) represents 15%–30% of adulthood glomerulopathies. Corticosteroids have been the main treatment for decades and are effective in 70% of minimal-change disease patients and ~30% of focal segmental glomerulosclerosis patients. Multidrug-resistant (steroids, calcineur...

Descripción completa

Detalles Bibliográficos
Autores principales: Naciri Bennani, Hamza, Jouve, Thomas, Noble, Johan, Rostaing, Lionel, Malvezzi, Paolo, Tetaz, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803719/
https://www.ncbi.nlm.nih.gov/pubmed/31687235
http://dx.doi.org/10.1155/2019/7304786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803719/
https://www.ncbi.nlm.nih.gov/pubmed/31687235
http://dx.doi.org/10.1155/2019/7304786

Ejemplares similares